Medicus Pharma Ltd. SEC filings MDCXW
Medicus Pharma Ltd. has 343 filings in SEC EDGAR's recent list, going back to Oct 13, 2023. Its latest annual report, Form ARS, was filed on May 4, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Nov 4, 2026 | Nov 4, 2026 |
| 425 | Form 425 | Nov 4, 2026 | — |
| DEF 14A | Proxy statement | Oct 30, 2026 | Dec 2, 2026 |
| 424B3 | Prospectus | Oct 26, 2026 | — |
| 8-K |
Current report
Listing notice, Other events
|
Oct 23, 2026 | Oct 20, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 19, 2026 | Dec 2, 2026 |
| 424B3 | Prospectus | Oct 16, 2026 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Oct 16, 2026 | Oct 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 16, 2026 | — |
| 424B3 | Prospectus | Oct 7, 2026 | — |
| 8-K |
Current report
Other events
|
Oct 7, 2026 | Oct 7, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Sep 14, 2026 | — |
| 424B3 | Prospectus | Sep 14, 2026 | — |
| 8-K |
Current report
Agreement ended
|
Sep 14, 2026 | Sep 11, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Sep 11, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 424B3 | Prospectus | Sep 3, 2026 | — |
| 8-K |
Current report
Material agreement
|
Sep 3, 2026 | Sep 2, 2026 |
| 424B3 | Prospectus | Aug 13, 2026 | — |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 424B3 | Prospectus | Jun 4, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 424B3 | Prospectus | May 28, 2026 | — |
| 8-K |
Current report
Material agreement, New debt, Listing notice
|
May 27, 2026 | May 20, 2026 |
| 424B3 | Prospectus | May 14, 2026 | — |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 5, 2026 | — |
| ARS | Annual report to shareholders | May 4, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | May 4, 2026 | Jun 3, 2026 |
| 424B3 | Prospectus | Apr 30, 2026 | — |
| 10-K/A | Amended annual report | Apr 29, 2026 | Dec 31, 2025 |
| 424B3 | Prospectus | Apr 27, 2026 | — |
| 8-K |
Current report
Material agreement, Listing notice
|
Apr 24, 2026 | Apr 21, 2026 |
| 424B3 | Prospectus | Apr 23, 2026 | — |
| PRE 14A | Preliminary proxy statement | Apr 21, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| EFFECT | Filing | Mar 27, 2026 | — |
| EFFECT | Filing | Mar 27, 2026 | — |
| EFFECT | Filing | Mar 27, 2026 | — |
| POS AM | Form pos am | Mar 25, 2026 | — |
| POS AM | Form pos am | Mar 25, 2026 | — |
| POS AM | Form pos am | Mar 25, 2026 | — |
| 424B3 | Prospectus | Mar 25, 2026 | — |
| 424B3 | Prospectus | Mar 25, 2026 | — |
| 424B3 | Prospectus | Mar 25, 2026 | — |
| 424B3 | Prospectus | Mar 25, 2026 | — |
| 10-K | Annual report | Mar 25, 2026 | Dec 31, 2025 |
| 424B3 | Prospectus | Mar 6, 2026 | — |
| 424B3 | Prospectus | Mar 6, 2026 | — |
| 424B3 | Prospectus | Mar 6, 2026 | — |
| 424B3 | Prospectus | Mar 6, 2026 | — |
| 253G2 | Form 253g2 | Mar 6, 2026 | — |
| 8-K |
Current report
Unregistered share sale
|
Mar 6, 2026 | Mar 5, 2026 |
| EFFECT | Filing | Feb 4, 2026 | — |
| CORRESP | Letter to the SEC | Jan 30, 2026 | — |
| S-3 | Shelf registration | Jan 30, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 15, 2026 | — |
| DRS | Filing | Jan 12, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 5, 2026 | — |
| 424B5 | Prospectus supplement | Jan 2, 2026 | — |
| EFFECT | Filing | Dec 31, 2025 | — |
| 424B3 | Prospectus | Dec 30, 2025 | — |
| 424B3 | Prospectus | Dec 30, 2025 | — |
| 424B3 | Prospectus | Dec 30, 2025 | — |
| 424B3 | Prospectus | Dec 30, 2025 | — |
| 253G2 | Form 253g2 | Dec 30, 2025 | — |
| 424B3 | Prospectus | Dec 30, 2025 | — |
| 424B3 | Prospectus | Dec 30, 2025 | — |
| 8-K |
Current report
Material agreement
|
Dec 30, 2025 | Dec 29, 2025 |
| S-3 | Shelf registration | Dec 30, 2025 | — |
| CORRESP | Letter to the SEC | Dec 29, 2025 | — |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| DRS | Filing | Dec 10, 2025 | — |
| 253G2 | Form 253g2 | Dec 8, 2025 | — |
| 424B3 | Prospectus | Dec 8, 2025 | — |
| 424B3 | Prospectus | Dec 8, 2025 | — |
| 424B3 | Prospectus | Dec 8, 2025 | — |
| 424B3 | Prospectus | Dec 8, 2025 | — |
| 424B3 | Prospectus | Dec 8, 2025 | — |
| 424B3 | Prospectus | Dec 8, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 8, 2025 | Dec 5, 2025 |
| 424B3 | Prospectus | Dec 5, 2025 | — |
| EFFECT | Filing | Dec 4, 2025 | — |
| CORRESP | Letter to the SEC | Dec 2, 2025 | — |
| 253G2 | Form 253g2 | Dec 1, 2025 | — |
| 424B3 | Prospectus | Dec 1, 2025 | — |
| 424B3 | Prospectus | Dec 1, 2025 | — |
| 424B3 | Prospectus | Dec 1, 2025 | — |
| 424B3 | Prospectus | Dec 1, 2025 | — |
| 424B3 | Prospectus | Dec 1, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 1, 2025 | Nov 28, 2025 |
| S-1 | Registration statement | Nov 19, 2025 | — |
| 424B3 | Prospectus | Nov 17, 2025 | — |
| 424B3 | Prospectus | Nov 17, 2025 | — |
| 424B3 | Prospectus | Nov 17, 2025 | — |
| 424B3 | Prospectus | Nov 17, 2025 | — |
| 424B3 | Prospectus | Nov 17, 2025 | — |
| 253G2 | Form 253g2 | Nov 17, 2025 | — |
| EFFECT | Filing | Nov 14, 2025 | — |
| EFFECT | Filing | Nov 14, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 14, 2025 | Nov 14, 2025 |
| S-8 | Employee stock plan registration | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 424B3 | Prospectus | Oct 17, 2025 | — |
| 424B3 | Prospectus | Oct 17, 2025 | — |
| 253G2 | Form 253g2 | Oct 17, 2025 | — |
| 424B3 | Prospectus | Oct 17, 2025 | — |
| 8-K |
Current report
Unregistered share sale
|
Oct 17, 2025 | Oct 16, 2025 |
| S-1 | Registration statement | Sep 29, 2025 | — |
| S-1 | Registration statement | Sep 29, 2025 | — |
| DRS | Filing | Sep 19, 2025 | — |
| 424B3 | Prospectus | Sep 18, 2025 | — |
| 424B3 | Prospectus | Sep 18, 2025 | — |
| 253G2 | Form 253g2 | Sep 18, 2025 | — |
| 424B3 | Prospectus | Sep 18, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Sep 18, 2025 | Sep 17, 2025 |
| 424B3 | Prospectus | Sep 15, 2025 | — |
| 424B3 | Prospectus | Sep 15, 2025 | — |
| 253G2 | Form 253g2 | Sep 15, 2025 | — |
| 424B3 | Prospectus | Sep 15, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Sep 12, 2025 | Sep 12, 2025 |
| DRS | Filing | Sep 11, 2025 | — |
| 3 | Initial insider ownership | Sep 8, 2025 | Aug 29, 2025 |
| 424B3 | Prospectus | Sep 2, 2025 | — |
| 424B3 | Prospectus | Sep 2, 2025 | — |
| 424B3 | Prospectus | Sep 2, 2025 | — |
| 253G2 | Form 253g2 | Sep 2, 2025 | — |
| 8-K |
Current report
Acquisition or sale of assets, Unregistered share sale, Officer or director change, Other events
|
Sep 2, 2025 | Aug 29, 2025 |
| 424B3 | Prospectus | Aug 22, 2025 | — |
| 424B3 | Prospectus | Aug 22, 2025 | — |
| 253G2 | Form 253g2 | Aug 22, 2025 | — |
| 424B3 | Prospectus | Aug 22, 2025 | — |
| 8-K |
Current report
Unregistered share sale, Other events
|
Aug 22, 2025 | Aug 21, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 4 | Insider transaction | Aug 14, 2025 | Aug 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2025 | — |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| 253G2 | Form 253g2 | Aug 12, 2025 | — |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 3/A | Ownership document | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
Aug 4, 2025 | Aug 4, 2025 |
| 3 | Initial insider ownership | Jul 31, 2025 | Jul 22, 2025 |
| 8-K |
Current report
Other events
|
Jul 30, 2025 | Jul 29, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 424B3 | Prospectus | Jul 23, 2025 | — |
| 424B3 | Prospectus | Jul 23, 2025 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MDCX (Nasdaq), MDCXW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Ontario, Canada
- Headquarters
- W. Conshohocken, PA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1997296
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.